Project Grant R41HL170893
Award Date
7/15/24
Completion Date
6/30/25
Dollars Obligated
$128K
Federal Agency
National Heart Lung and Blood Institute
Federal Grant Program
93.837
Assistance Type
Project Grant
Place of Performance
Louisville, KY 40206, USA
Similar Awards
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) provides $301,224 to PGXL Technologies LLC, a minority-owned for-profit company, to develop a urine-based, multiplex immunoassay for screening children for obstructive sleep apnea (OSA). The goal is to advance the development of this non-invasive diagnostic technology through initial clinical validation. The project will integrate assays for the...
The National Heart, Lung, and Blood Institute (NHLBI), a division of the National Institutes of Health (NIH), awarded a $1,231,242 Project Grant under the Cardiovascular Diseases Research (CFDA 93.837) program to Powell Mansfield, Inc. for the "BREATH: Breakthrough Research in Electromyography for the Assessment of Sleep-Disordered Breathing" project. This 12-month project aims to develop and validate a diagnostic tool called Deep Learning-Enhanced Transmembranous Electromyography...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research CFDA program (93.837), aims to improve the diagnosis of obstructive sleep apnea (OSA) in primary care clinics. The $740,271 grant, awarded on August 15, 2024, will fund a study to determine the prevalence of undiagnosed OSA and identify barriers to OSA diagnosis in primary care settings. The research will involve two stages: 1) epidemiological assessment of...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), will fund the development and validation of a novel wearable sensor system called "SleepTronix" to comprehensively assess sleep, breathing patterns, and circadian rhythms in individuals with obstructive sleep apnea (OSA). The $253,500 award will be used to refine the SleepTronix system, which monitors physiological signals such as EEG,...
This $332,862 federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) supports a study to assess night-to-night variability in novel obstructive sleep apnea (OSA) severity metrics and their impact on daytime functioning. The study will leverage cutting-edge sleep monitoring technology and ecological momentary assessments to enroll 300 participants (100 men, 200 women) from two sleep medicine...
This $1,420,164 Project Grant award from the National Heart, Lung, and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) supports research to simultaneously evaluate brain oxygen metabolism and upper airway anatomy in patients with obstructive sleep apnea (OSA). The key objectives are to: 1) optimize an MRI protocol to monitor metabolic and structural changes during induced apneas; 2) examine how OSA disease severity impacts oxygen metabolism and airway anatomy in patients during...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), aims to develop an advanced monitoring system for accurately detecting and classifying apnea of prematurity (AOP) in newborns. The two-phase project, with a total funding of $371,021, will be carried out by Makani Science Inc. from April 2025 to February 2027. During the initial R61 phase, the project will focus on developing a multimodal hardware...
This federal Project Grant award, provided by the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), is funding research to investigate the impact of obstructive sleep apnea (OSA) on vascular senescence and dysfunction. The $745,121 award to the University of Missouri System will utilize three transgenic mouse models to study how chronic exposures to intermittent hypoxia and sleep fragmentation, key features of OSA, induce...
The National Heart, Lung, and Blood Institute (NHLBI) awarded a $1,602,357 Project Grant under the Cardiovascular Diseases Research program (CFDA 93.837) to KDH Research & Communication, Inc., a woman-owned small business. The grant will support the development and evaluation of the "Personalized Approach to Habits-Sleep" (PATH-S) mobile app. The PATH-S app aims to improve sleep duration and decrease asthma symptoms in Black teens aged 14-17 with asthma by using gamification and...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) provides $1,534,832 to the University of Pittsburgh to develop accessible sleep EEG growth charts for young people. The project aims to create normative age-based reference models for sleep physiology measures in typically developing individuals aged 9-26 years using both polysomnography and a wearable sleep recording device. This research...